Peptide Decoded

Having a high appetite while being on a high dose of Retatrutide is one of the most underlooked and amazing phenomena’s in the peptide industry. Most people think appetite suppression is the entire goal, but retatrutide’s glucagon activity will increase energy expenditure and nutrient utilization beyond just “eating less.” In many cases, people are able to eat more, train harder, recover better, maintain muscle fullness, and still lose fat at a high rate. That’s a very different, and better, environment than traditional crash dieting where metabolism, performance, and energy all tank just to get lean.

Retatrutide VS Tirzepatide at a glance… Those side effect numbers for retatrutide are no joke… Went a little deeper in the article below… $LLY

These numbers are shocking. It's like we got a new frontier AI model but for the body. Lilly's phase 3 results for retatrutide: > highest dose lost 28.3% of body weight in 80 wks > 70 lbs ave > 45% lost 30% or more of their body weight > 65% on the top dose no longer clinically obese Retatrutide is more dynamic than semaglutide and tirzepatide because it targets three receptors (GIP, GLP-1, and glucagon), versus one and two, respectively. Side effects, on the highest dose (12mg), were higher for retatrutide than tirzepatide (nausea and GI), with an 11.3% drop out rate. The lowest 4mg dose still delivered 19% loss with fewer dropouts than placebo.